Skip to main content
Advertisement
Advertisement
KMTS
KMTS logo
Kestra Medical Technologies, Ltd. Common Stock
26.63
USD
Sponsored
-1.66
-5.87%
Nov 19, 15:59 UTC -5
Closed
exchange

After-Market

26.65

+0.02
+0.08%

Kestra Medical Technologies, Ltd. Common Stock (KMTS) Earnings

KMTS Earnings Reports

Positive Surprise Ratio

KMTS beat 1 of 6 last estimates.

17%

Next Report

Date of Next Report
Dec 10, 2026
Estimate for Q2 27 (Revenue/ EPS)
$32.73M
/
-$0.61
Implied change from Q1 27 (Revenue/ EPS)
+5.68%
/
-6.15%
Implied change from Q2 26 (Revenue/ EPS)
+45.05%
/
-4.69%

Kestra Medical Technologies, Ltd. Common Stock earnings per share and revenue

On Sep 14, 2026, KMTS reported earnings of -0.65 USD per share (EPS) for Q1 27, missing the estimate of -0.62 USD, resulting in a -3.47% surprise. Revenue reached 30.97 million, compared to an expected 29.59 million, with a 4.68% difference. The market reacted with a +4.66% price change (close before vs. close after earnings).
Looking ahead to Q2 27, 9 analysts forecast an EPS of -0.61 USD, with revenue projected to reach 32.73 million USD, implying an decrease of -6.15% EPS, and increase of 5.68% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%
logo
Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
-$0.16
Surprise
-361.44%
logo
Oramed Pharmaceuticals Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.43
Actual
$0.43
Surprise
-1.96%
logo
MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%
logo
Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%
logo
Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-
Actual
$0.10
Surprise
-
logo
FitLife Brands, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.24
Actual
$0.16
Surprise
-34.64%
logo
Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%
logo
Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%
logo
Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%
FAQ
For Q1 2027, Kestra Medical Technologies, Ltd. Common Stock reported EPS of -$0.65, missing estimates by -3.47%, and revenue of $30.97M, 4.68% above expectations.
The stock price moved up 4.66%, changed from $24.06 before the earnings release to $25.18 the day after.
The next earning report is scheduled for Dec 10, 2026.
Based on 9 analysts, Kestra Medical Technologies, Ltd. Common Stock is expected to report EPS of -$0.61 and revenue of $32.73M for Q2 2027.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement